The use of antidepressants when breast-feeding;Antidepressiver og amming

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 27, 1997, Pages 3952-3955

  Håberg, Margret ^a   Matheson, Ingrid ^b  

^a Rogaland Psykiatriske Sjukehus ^*  (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; FONTEX; IMIPRAMINE; LITHIUM; LITHIUM CITRATE; MIANSERIN; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTISOL; UNCLASSIFIED DRUG; VENLAFAXINE;

BREAST FEEDING; BREAST MILK; DRUG MILK LEVEL; FEMALE; HUMAN; PUERPERAL DEPRESSION; SHORT SURVEY;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BREAST FEEDING; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LITHIUM; MIANSERIN; MILK, HUMAN; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0030669714     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Knops GG. Postpartum mood disorders. Postgrad Med 1993; 3: 103-16.
2. Hopkins J, Marais M, Campell S. Post partum depression: a critical review. Psychol Bull 1984; 95: 498-515.
3. Matheson I, Nylander G. Amming og legemidler. I: Norsk legemiddelhåndbok 1996-97 for helsepersonell. Oslo: Norsk legemiddelhåndbok I/S, 1996.
4. Sharp D, Hay DF, Pawlby S. Schücker G, Allen H, Kumar R. The impact of postnatal depression on boys' intellectual development. J Child Psychol Psychiatry 1995; 36: 1315-36.
5. Bennett PN, red. Drugs and human lactation. 2. utg. Amsterdam: Elsevier, 1996.
6. Spigset O, Carleborg L, Norstrom A, Sandlund M. Paroxetine level in breast milk. J Clin Psychiatry 1996; 57: 39.
7. Taddio A, Ito S, Keren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996; 36: 42-7.
8. Hatzopoulos FK, Albrecht LM. Antidepressant use during breastfeeding. J Hum Lact 1996; 12: 139-41.
9. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk. Br J Clin Pharmacol 1991; 31: 209.
10. Altshurler LL, Burt VK, McMullen M, Hendrick V. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995; 56: 243-5.
11. Epperson CN, Andersen GM, McDougle CJ. Sertraline and breast-feeding. N Engl J Med 1997; 336: 1189-90.
12. Mammen OK, Perel JM, Rudolph G, Foglia JP, Wheeler SB. Sertraline and norsertraline levels in three breast-fed infants. J Clin Psychiatry 1997; 58: 100-3.
13. Buist A, Norman TR, Dennerstein L. Mianserin in breast milk. Br J Clin Pharmacol 1993; 36: 133-4.
14. Pons G, Schoerlin MG, Tam YK, Moran C, Pfefen IP, Francaual C et al. Moclobemide excretion in human breast milk. Br J Clin Pharmacol 1990; 29: 27-31.
15. Buist A, Janson H. Effect of exposure to dothiepin and northiaden in breast milk on child development. Br J Psychiatry 1995; 167: 370-3.
16. Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 1985; 2: 1124.
17. Skausig OB, Schou M. Breast feeding during lithium treatment. Ugeskr Læger 1977; 139: 400-1.
18. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations. Clin Pharmacokinet 1994; 27: 270-89.
19. Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991; 21: 157-71.
20. Wisner KL, Perel IM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153: 1132-7.
21. Lidén K, Eilström KG. Även låga doser kan påverka barnet. Låkartidningen 1997; 94: 2086-7.